Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May 31;28(2):161-202.
doi: 10.14701/ahbps.23-170. Epub 2024 Apr 29.

Practice guidelines for managing extrahepatic biliary tract cancers

Affiliations

Practice guidelines for managing extrahepatic biliary tract cancers

Hyung Sun Kim et al. Ann Hepatobiliary Pancreat Surg. .

Abstract

Backgrounds/aims: Reported incidence of extrahepatic bile duct cancer is higher in Asians than in Western populations. Korea, in particular, is one of the countries with the highest incidence rates of extrahepatic bile duct cancer in the world. Although research and innovative therapeutic modalities for extrahepatic bile duct cancer are emerging, clinical guidelines are currently unavailable in Korea. The Korean Society of Hepato-Biliary-Pancreatic Surgery in collaboration with related societies (Korean Pancreatic and Biliary Surgery Society, Korean Society of Abdominal Radiology, Korean Society of Medical Oncology, Korean Society of Radiation Oncology, Korean Society of Pathologists, and Korean Society of Nuclear Medicine) decided to establish clinical guideline for extrahepatic bile duct cancer in June 2021.

Methods: Contents of the guidelines were developed through subgroup meetings for each key question and a preliminary draft was finalized through a Clinical Guidelines Committee workshop.

Results: In November 2021, the finalized draft was presented for public scrutiny during a formal hearing.

Conclusions: The extrahepatic guideline committee believed that this guideline could be helpful in the treatment of patients.

Keywords: Bile duct cancer; Extrahepatic; Guidlines.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

No potential conflict of interest relevant to this article was reported.

References

    1. Choi M, Kim NS, Sheen SS, Ki SM, Lee SJ, Kim JY. The status and dissemination plan of clinical practice guideline in Korea. NECA; 2015.
    1. Choi M, Kim NS, Jung Y, Lee SJ, Son SK, Lyu DH. Promoting the quality of medicine: based on clinical practice guidelines. NECA; 2015.
    1. Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. Development of the AGREE II, part 1: performance, usefulness and areas for improvement. CMAJ. 2010;182:1045–1052. doi: 10.1503/cmaj.091714. - DOI - PMC - PubMed
    1. Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. Development of the AGREE II, part 2: assessment of validity of items and tools to support application. CMAJ. 2010;182:E472–478. doi: 10.1503/cmaj.091716. - DOI - PMC - PubMed
    1. Kim SY, Park JE, Lee YJ, Seo HJ, Sheen SS, Hahn S, et al. Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity. J Clin Epidemiol. 2013;66:408–414. doi: 10.1016/j.jclinepi.2012.09.016. - DOI - PubMed

LinkOut - more resources